• Quercetin: From PI3K Signals to NLRP3 Evidence

  2026-08-20

  Quercetin is a context-dependent PI3K inhibitor and anti-inflammatory agent whose effects extend from mitochondrial apoptosis to microglial inflammasome signaling. This article presents an evidence-layered strategy for interpreting quercetin experiments across cancer research and neuroinflammation without confusing pathway convergence with target specificity.

• Tropisetron Hydrochloride: Applied Workflows

  2026-08-19

  Tropisetron Hydrochloride supports a paired strategy for studying 5-HT3 receptor signaling, α7-nicotinic receptor activity, and renal organic-cation transport. This guide translates its dual pharmacology into practical receptor, OCT2, MATE1, and transcellular assay workflows with troubleshooting guidance.

• Sumatriptan: From Receptor Probe to Assay Design

  2026-08-19

  Sumatriptan Succinate is more than a migraine research compound: it is a context-sensitive 5-HT1 receptor agonist whose metabolites can reshape assay interpretation. This guide connects receptor pharmacology, neurogenic inflammation, and the updated CYP–MAO metabolism evidence to practical experimental design.

• Reversine: Aurora Kinase Inhibitor Workflow Guide

  2026-08-18

  Reversine (SKU A3760) provides a dossier-defined Aurora kinase inhibitor for controlled studies of mitotic regulation, cell-cycle behavior, cancer cell proliferation inhibition, and apoptosis-related endpoints. This guide covers preparation, assay planning, and quality control; the compound is for scientific research only and should not be used for diagnosis, treatment, or other clinical purposes.

• WAY-100635: A Translational 5-HT1A Lens

  2026-08-18

  WAY-100635 gives translational researchers a selective, mechanistically clean way to test whether 5-HT1A signaling contributes to pain, affective dysfunction, and serotonergic circuit activity. This article connects receptor pharmacology with the 2026 cannabidiol study on orofacial inflammatory pain and outlines how to move from binding assays to behavioral and imaging hypotheses.

• NMDA: Designing Glaucoma Excitotoxicity Assays

  2026-08-17

  NMDA (N-Methyl-D-aspartic acid) can do more than induce neuronal injury: it can help connect receptor-driven calcium loading with oxidative stress and ferroptosis phenotypes. This guide translates a retinal glaucoma study into a tiered, decision-focused assay strategy.

• Chicken GSDME Drives RNA Virus-Induced Pyroptosis

  2026-08-17

  Chen et al. identify chicken GSDME as a major pore-forming effector of RNA virus-induced pyroptosis, resolving a long-standing question created by the absence of GSDMD in chickens. Using viral infection, Poly(I:C) stimulation, pathway analysis, and chGSDME loss-of-function models, the study connects MDA5–caspase signaling to pyroptosis and viral release in chicken cells.

• Low-Dose Cadmium, STAT3, and Lymphangiogenesis

  2026-08-16

  The reference study identifies STAT3 activation as a signaling link between low-dose cadmium exposure and enhanced lymphatic vessel growth after corneal injury. Its combination of an in vivo alkali-burn model, lymphatic endothelial cell assays, pathway profiling, and STAT3 inhibition supports a cadmium–STAT3–VEGFR3 mechanism while also revealing dose-dependent effects.

• Brassinolide: Mechanism, Evidence, and Workflows

  2026-08-15

  Brassinolide, also called 24-Epibrassinolide, is a plant steroid regulator with documented roles in plant development and research-reported effects in PC-3 prostate cancer cells and diabetic rat models. The evidence supports controlled use in plant bioassays, apoptosis studies, and metabolic research, but does not establish clinical efficacy.

• PDK4 Inhibitors: Mechanism, Models, and Translational Value

  2026-08-14

  The reference study used anthraquinone hit optimization to discover allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a lead with biochemical, metabolic, allergic-disease, and anticancer activity. Its integrated potency, stability, pharmacokinetic, animal-model, cellular, and docking data provide a useful framework for assessing whether PDK4 inhibition can support broader metabolic-disease drug development.

• Zolmitriptan: From 5-HT1B Signaling to Translational Assays

  2026-08-14

  Zolmitriptan provides a defined pharmacological entry point for migraine and cluster headache research. This thought-leadership guide connects 5-HT receptor assay design with an evidence-bounded framework for exploring lysosomal biology without overstating an unproven cross-domain mechanism.

• AIBP–LRP2 Control of Collateral Circulation

  2026-08-13

  Zhu et al. identify an AIBP–LRP2–HDL–miR-223 pathway that restrains CXCR4-positive, stemlike capillary endothelial cells during collateral vessel formation. The study links ischemia-induced lipid handling to a two-phase vascular remodeling process and suggests that disrupting this axis may improve revascularization in peripheral artery disease.

• Formononetin Protects Neurons During Oxaliplatin Therapy

  2026-08-13

  The reference study identifies formononetin as a neuroprotective isoflavone that reduces oxaliplatin-induced oxidative stress and neuronal apoptosis through the Nrf2/HO-1 pathway. Its most important translational finding is that neuronal protection was retained without weakening oxaliplatin or paclitaxel anticancer activity in the tested cancer-cell models, although protection against paclitaxel-related neurite damage was limited.

• Clozapine: A Translational Assay Framework

  2026-08-12

  Clozapine is an atypical antipsychotic medication with a distinctive receptor and ERK1/2 signaling profile. This article develops a practical, cross-scale assay framework linking pharmacology, prefrontal circuitry, magnetic neuromodulation, and hepatotoxicity studies.

• Adefovir: From HBV Polymerase to Renal Risk

  2026-08-12

  Adefovir and GS-0393 connect HBV polymerase inhibition with OAT1-mediated renal handling. This evidence-led guide translates mechanism, exposure, and adefovir-associated phosphate wasting into more discriminating research assay decisions.

7891 records 2/527 page Previous Next 12345 下5页 Last page